Mineralys Therapeutics, Inc. (MLYS) › Capital ExpendituresMineralys Therapeutics, Inc. (MLYS) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $02024: $96.0K2025: $15.0K$15.0K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$15.0K-84.4%2024$96.0K—2023$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share